Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) today announces its financial calendar for 2017, which is set as follows:
- March 7, 2017:
Publication of 2016 financial statements, with management comments
The 2016 Reference Document and Financial Report (included in the Reference Document) will be released during the second quarter of 2017.
- May 15, 2017:
Publication of revenue for 1Q2017, with management comments
- June 23, 2017:
Annual shareholders meeting in Marseille
- September 18, 2017:
Publication of financial statements as of June 30, 2017, with management comments
- November 15, 2017:
Publication of revenue for 3Q2017, with management comments
All corporate information on the Company, such as its financial statements or its corporate presentations, is available on the Company’s website in the Investors’ section (http://www.innate-pharma.com/en/investors).